Home News Results

Tianjin Zhong Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million

Atiqah Mokhtar
Atiqah Mokhtar4/29/2021 5:45 PM GMT+08  • 1 min read
Tianjin Zhong Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million
The higher earnings follow increased sales in tandem with China's economic recovery.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Tianjin Zhong Xin Pharmaceutical Group Corporation has reported earnings of RMB213 million ($43.5 million) for its 1QFY2021 ended March, up 25% y-o-y.

The higher earnings follow an increase in revenue for the period, which climbed 10% y-o-y from RMB1.65 billion to RMB1.83 billion on the back of higher sales in tandem with China’s recovering economy.

Gross profit for the 1QFY2021 grew 13% y-o-y to RMB753.4 million, with gross profit margin was 41.2%, up 1.2 percentage points from the previous year.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.